Advisory - Several drugs containing valsartan being recalled due to contamination with a potential carcinogen

OTTAWA, July 9, 2018 /CNW/ -

Issue: Several drugs containing the ingredient valsartan are being recalled by their manufacturers. An impurity, N-nitrosodimethylamine (NDMA), was found in the valsartan used in......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - 6 days ago

Share |